PETER PEKOS - Net Worth and Insider Trading

PETER PEKOS Net Worth

The estimated net worth of PETER PEKOS is at least $8,436 dollars as of 2024-11-12. PETER PEKOS is the Director of Cardiol Therapeutics Inc and owns about 3,090 shares of Cardiol Therapeutics Inc (TSX:CRDL) stock worth over $8,436. Details can be seen in PETER PEKOS's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that PETER PEKOS has not made any transactions after 2019-10-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of PETER PEKOS

To

PETER PEKOS Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, PETER PEKOS owns 1 companies in total, including Cardiol Therapeutics Inc (TSX:CRDL) .

Click here to see the complete history of PETER PEKOS’s form 4 insider trades.

Insider Ownership Summary of PETER PEKOS

Ticker Comapny Transaction Date Type of Owner
TSX:CRDL Cardiol Therapeutics Inc 2019-10-17 Director

PETER PEKOS Latest Holdings Summary

PETER PEKOS currently owns a total of 1 stock. PETER PEKOS owns 3,090 shares of Cardiol Therapeutics Inc (TSX:CRDL) as of October 17, 2019, with a value of $8,436.

Latest Holdings of PETER PEKOS

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:CRDL Cardiol Therapeutics Inc 2019-10-17 3,090 2.73 8,436

Holding Weightings of PETER PEKOS


PETER PEKOS Form 4 Trading Tracker

According to the SEC Form 4 filings, PETER PEKOS has made a total of 0 transactions in Cardiol Therapeutics Inc (TSX:CRDL) over the past 5 years. The most-recent trade in Cardiol Therapeutics Inc is the acquisition of 3,090 shares on October 17, 2019, which cost PETER PEKOS around $10,753.

Insider Trading History of PETER PEKOS

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

PETER PEKOS Trading Performance

GuruFocus tracks the stock performance after each of PETER PEKOS's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by PETER PEKOS is -10.96%. GuruFocus also compares PETER PEKOS's trading performance to market benchmark return within the same time period. The performance of stocks bought by PETER PEKOS within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how PETER PEKOS's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of PETER PEKOS

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.16 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -4.19 LIMIT LIMIT LIMIT LIMIT LIMIT

PETER PEKOS Ownership Network

Ownership Network List of PETER PEKOS

No Data

Ownership Network Relation of PETER PEKOS

Insider Network Chart

PETER PEKOS Owned Company Details

What does Cardiol Therapeutics Inc do?

Who are the key executives at Cardiol Therapeutics Inc?

PETER PEKOS is the Director of Cardiol Therapeutics Inc. Other key executives at Cardiol Therapeutics Inc include Senior Officer Guillermo Torre , Director & Senior Officer David Elsley , and Director & Senior Officer Christopher James Waddick .

Cardiol Therapeutics Inc (TSX:CRDL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cardiol Therapeutics Inc (TSX:CRDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cardiol Therapeutics Inc Insider Transactions

No Available Data

PETER PEKOS Mailing Address

Above is the net worth, insider trading, and ownership report for PETER PEKOS. Currently GuruFocus does not have mailing address information for PETER PEKOS.